MOTS-C
Unit Size | 10 mg/vial |
Unit Quantity | 1 Vial |
Molecular Formula | C101H152N28O22S2 |
Molecular Weight | 4963.44 |
Sequence | H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH |
Appearance | White Powder |
Peptide Purity | >98.1% |
Solubility | Soluble in water or 1% acetic acid |
The potential of MOTS-C to assist postmenopausal women in overcoming metabolic hurdles, such as obesity and insulin resistance, highlights its therapeutic promise. Beyond these applications, MOTS-C is under investigation for its potential to contribute to anti-aging strategies, improve physical performance, and alleviate aging-related decline.
In cardiovascular health, MOTS-C has demonstrated potential in preventing vascular calcification, a process linked to cardiovascular disease. This is achieved through the activation of AMPK signaling, a crucial regulator of cellular energy balance. Additionally, MOTS-C is believed to enhance muscle efficiency during exercise, supporting mitochondrial functionality and optimizing energy metabolism, making it an area of interest for both medical research and those seeking to improve their physical performance and metabolic health.
Please be aware that the information provided is based on scientific research and is for educational and informational purposes only. It is the subject of ongoing studies to further understand its potential and applications. Individuals should consult healthcare professionals before considering any peptide for therapeutic use.
OFFICIAL PARTNERS: